the partners

news

  • 2018/07/02

    An EPIICAL paper has been accepted for publication in the Journal of Acquired Immune Deficiency Syndromes (JAIDS)

    read more
  • 2018/06/19

    The EPIICAL Consortium is pleased to announce that the enrollment of the EARTH study is moving fast.

    read more
  • 2018/05/21

    It is with great pleasure that we announce that the first patient in the EARTH study has been recruited. Ths […]

    read more

publications

  • Early and highly suppressive ART are main factors associated with low viral reservoir in European perinatally HIV infected children

    2018/06/26

    Future strategies aiming to achieve HIV-1 remission are likely to target individuals with small reservoir size. We retrospectively investigated factors associated with HIV-1 DNA levels in European, perinatally HIV-infected children starting ART <6 months of age.

    read more

  • Report from the First EPIICAL General Assembly meeting, 9–11 November 2017, Rome, Italy

    2018/01/22

    The first EPIICAL General Assembly meeting was held in an atmosphere of growing optimism. Many novel and exciting proposals for HIV research studies were […]

    read more

  • The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

    2016/02/01

    The EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies) project arises from the firm belief […]

    read more

  • Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission

    2015/12/21

    From the use of antiretroviral therapy to prevent mother-to-child transmission to the possibility of HIV cure hinted at by the […]

    read more